Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Bullinger

Showing results (91-100 of 385) with videos related to

Pageof 39
Sort By:
Haematologica|October 15, 2020
Transcription factor 4 (<i>TCF4</i>) expression predicts clinical outcome in <i>RUNX1</i> mutated and translocated acute myeloid leukemiaFlorentien E M In't Hout, Mylène Gerritsen, Lars Bullinger, et al.
Haematologica|March 3, 2022
Clonal hematopoiesis of indeterminate potential-related epigenetic age acceleration correlates with clonal hematopoiesis of indeterminate potential clone size in patients with high morbidityJasper David Feldkamp, Valentin Max Vetter, Christopher Maximilian Arends, et al.
Blood|December 23, 2016
Cancer-specific changes in DNA methylation reveal aberrant silencing and activation of enhancers in leukemiaYing Qu, Lee Siggens, Lina Cordeddu, et al.
Hemasphere|December 23, 2020
Gene Expression Profiling Predicts Sensitivity of Chronic Lymphocytic Leukemia Cells to DasatinibTamara J Blätte, Marcin M Machnicki, Eliza Glodkowska-Mrowka, et al.
Oncotarget|June 2, 2018
MYB induces the expression of the oncogenic corepressor SKI in acute myeloid leukemiaMiriam Frech, Sabine Teichler, Christine Feld, et al.
Frontiers in Immunology|February 27, 2025
Advanced disease and CD8<sup>+</sup> TEMRA cells predict severe infections in multiple myelomaEva Tranter, David Busch, Clarissa Heck, et al.
Frontiers in Oncology|January 22, 2025
Real-world experience with TTFields in glioma patients with emphasis on therapy usageClaudius Jelgersma, Joan Alsolivany, Gülsüm Akkas, et al.
Cell Stem Cell|April 10, 2012
Genetic and pharmacologic inhibition of β-catenin targets imatinib-resistant leukemia stem cells in CMLFlorian H Heidel, Lars Bullinger, Zhaohui Feng, et al.
British Journal of Haematology|January 13, 2010
KIT mutations confer a distinct gene expression signature in core binding factor leukaemiaSonja C Lück, Annika C Russ, Juan Du, et al.
Epigenetics|June 17, 2016
Molecular dissection of valproic acid effects in acute myeloid leukemia identifies predictive networksFrank G Rücker, Katharina M Lang, Markus Fütterer, et al.
Pageof 39

Showing results (91-100 of 385) with videos related to

Sort By:
Pageof 39
Haematologica|October 15, 2020
Transcription factor 4 (<i>TCF4</i>) expression predicts clinical outcome in <i>RUNX1</i> mutated and translocated acute myeloid leukemiaFlorentien E M In't Hout, Mylène Gerritsen, Lars Bullinger, et al.
Haematologica|March 3, 2022
Clonal hematopoiesis of indeterminate potential-related epigenetic age acceleration correlates with clonal hematopoiesis of indeterminate potential clone size in patients with high morbidityJasper David Feldkamp, Valentin Max Vetter, Christopher Maximilian Arends, et al.
Blood|December 23, 2016
Cancer-specific changes in DNA methylation reveal aberrant silencing and activation of enhancers in leukemiaYing Qu, Lee Siggens, Lina Cordeddu, et al.
Hemasphere|December 23, 2020
Gene Expression Profiling Predicts Sensitivity of Chronic Lymphocytic Leukemia Cells to DasatinibTamara J Blätte, Marcin M Machnicki, Eliza Glodkowska-Mrowka, et al.
Oncotarget|June 2, 2018
MYB induces the expression of the oncogenic corepressor SKI in acute myeloid leukemiaMiriam Frech, Sabine Teichler, Christine Feld, et al.
Frontiers in Immunology|February 27, 2025
Advanced disease and CD8<sup>+</sup> TEMRA cells predict severe infections in multiple myelomaEva Tranter, David Busch, Clarissa Heck, et al.
Frontiers in Oncology|January 22, 2025
Real-world experience with TTFields in glioma patients with emphasis on therapy usageClaudius Jelgersma, Joan Alsolivany, Gülsüm Akkas, et al.
Cell Stem Cell|April 10, 2012
Genetic and pharmacologic inhibition of β-catenin targets imatinib-resistant leukemia stem cells in CMLFlorian H Heidel, Lars Bullinger, Zhaohui Feng, et al.
British Journal of Haematology|January 13, 2010
KIT mutations confer a distinct gene expression signature in core binding factor leukaemiaSonja C Lück, Annika C Russ, Juan Du, et al.
Epigenetics|June 17, 2016
Molecular dissection of valproic acid effects in acute myeloid leukemia identifies predictive networksFrank G Rücker, Katharina M Lang, Markus Fütterer, et al.
Pageof 39